Table 2.
Baseline plasma neurohormone levels in patients with and without diabetes.
| Diabetes | No diabetes | P value | |
|---|---|---|---|
| Number of patients (%) | 81 (22) | 290 (78) | |
| Noradrenaline (pg/ml) | 507 (371-692) | 497 (362-700) | 0.52 |
| Adrenaline (pg/ml) | 34 (22-62) | 41 (27-69) | 0.16 |
| Dopamine (pg/ml) | 20 (13-31) | 20 (13-33) | 0.24 |
| Aldosterone (pg/ml) | 93 (65-205) | 120 (67-228) | 0.54 |
| Renin (μU/ml) | 64 (27-217) | 87 (41-229) | 0.46 |
| Endothelin (pg/ml) | 4.9 (3.2-10.1) | 5.6 (3.5-13.9) | 0.12 |
| ANP (pmol/l) | 103 (76-196) | 104 (59-177) | 0.66 |
| N-terminal (pro)ANP (pmol/l) | 1174 (651-1930) | 1067 (623-1743) | 0.99 |
| BNP (pmol/l) | 94 (26-145) | 47 (17-108) | 0.03 |
| N-terminal (pro)BNP (pmol/l) | 750 (383-1460) | 554 (253-1107) | 0.10 |
Data are median (IQR) unless otherwise indicated. All plasma neurohormones were available in 369 out of 371 patients except for N-terminal (pro)BNP which was available in 311 patients.